Found 17 matching trials
Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects PHASE1 This is a Phase 1 open-label, randomized, two-period, crossover study to ev...
Show More Learn More & Join Trial
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis PHASE3 This is a Phase 3, randomized, multicenter, double-blind, placebo-controlle...
Show More Learn More & Join Trial
ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects PHASE1 This is a Phase 1, open-label, single-centre, non-randomised study to evalu...
Show More Location
Quotient Sciences
Learn More & Join Trial
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole PHASE3 This is a multicenter, randomized, double-blind study of two treatment regi...
Show More Location
University of Alabama at Birmingham School of Medicine
Learn More & Join Trial
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) PHASE3 This study is a Phase 3, multicenter, randomized, double-blind, placebo-con...
Show More Location
Precision Trials LLC
Learn More & Join Trial
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis PHASE2 Study to evaluate the safety and efficacy of coadminstration of SCY-078 wit...
Show More Location
Brigham Womens Hospital INF 75 Francis Street PBB-A4
Learn More & Join Trial
Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis PHASE3 This study will treat subjects with complicated VVC who have failed prior f...
Show More Location
Precision Trials, AZ
Learn More & Join Trial
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) PHASE3 This is a Phase 3, randomized, multicenter, double-blind, placebo-controlle...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis PHASE2 The purpose of this study is to compare the safety, pharmacokinetics, and e...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects PHASE1 This is a Phase 1, open-label, single center, non-randomized study to evalu...
Show More Location
Quotient Sciences Limited
Learn More & Join Trial